These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21199445)

  • 21. Reduced neuro-integration from the dorsolateral prefrontal cortex to the whole brain and executive dysfunction in schizophrenia patients and their relatives.
    Su TW; Lan TH; Hsu TW; Biswal BB; Tsai PJ; Lin WC; Lin CP
    Schizophr Res; 2013 Aug; 148(1-3):50-8. PubMed ID: 23726722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aerobic exercise for cognitive deficits in schizophrenia - The impact of frequency, duration, and fidelity with target training intensity.
    Kimhy D; Lauriola V; Bartels MN; Armstrong HF; Vakhrusheva J; Ballon JS; Sloan RP
    Schizophr Res; 2016 Apr; 172(1-3):213-5. PubMed ID: 26852401
    [No Abstract]   [Full Text] [Related]  

  • 23. Association of IQ Changes and Progressive Brain Changes in Patients With Schizophrenia.
    Kubota M; van Haren NE; Haijma SV; Schnack HG; Cahn W; Hulshoff Pol HE; Kahn RS
    JAMA Psychiatry; 2015 Aug; 72(8):803-12. PubMed ID: 26083394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of psychophysical, electrophysiological, and fMRI assessment of visual contrast responses in patients with schizophrenia.
    Calderone DJ; Martinez A; Zemon V; Hoptman MJ; Hu G; Watkins JE; Javitt DC; Butler PD
    Neuroimage; 2013 Feb; 67():153-62. PubMed ID: 23194815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain mapping biomarkers of socio-emotional processing in schizophrenia.
    Taylor SF; MacDonald AW;
    Schizophr Bull; 2012 Jan; 38(1):73-80. PubMed ID: 21965468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An investigation of the relationship between activation of a social cognitive neural network and social functioning.
    Pinkham AE; Hopfinger JB; Ruparel K; Penn DL
    Schizophr Bull; 2008 Jul; 34(4):688-97. PubMed ID: 18477583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Functional imaging of emotional disorders and experiences in schizophrenia patients].
    Habel U; Kircher T; Schneider F
    Radiologe; 2005 Feb; 45(2):161-8. PubMed ID: 15696318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural correlates of cognitive deficit and elevated gamma noise power in schizophrenia.
    Suazo V; Díez Á; Montes C; Molina V
    Psychiatry Clin Neurosci; 2014 Mar; 68(3):206-15. PubMed ID: 24313632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical, functional, and intertask correlations of measures developed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia Consortium.
    Gold JM; Barch DM; Carter CS; Dakin S; Luck SJ; MacDonald AW; Ragland JD; Ranganath C; Kovacs I; Silverstein SM; Strauss M
    Schizophr Bull; 2012 Jan; 38(1):144-52. PubMed ID: 22101961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of White Matter With Core Cognitive Deficits in Patients With Schizophrenia.
    Kochunov P; Coyle TR; Rowland LM; Jahanshad N; Thompson PM; Kelly S; Du X; Sampath H; Bruce H; Chiappelli J; Ryan M; Fisseha F; Savransky A; Adhikari B; Chen S; Paciga SA; Whelan CD; Xie Z; Hyde CL; Chen X; Schubert CR; O'Donnell P; Hong LE
    JAMA Psychiatry; 2017 Sep; 74(9):958-966. PubMed ID: 28768312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neural correlates of cognitive impairment in schizophrenia.
    Ortiz-Gil J; Pomarol-Clotet E; Salvador R; Canales-Rodríguez EJ; Sarró S; Gomar JJ; Guerrero A; Sans-Sansa B; Capdevila A; Junqué C; McKenna PJ
    Br J Psychiatry; 2011 Sep; 199(3):202-10. PubMed ID: 21727234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neural bases for impaired social cognition in schizophrenia and autism spectrum disorders.
    Pinkham AE; Hopfinger JB; Pelphrey KA; Piven J; Penn DL
    Schizophr Res; 2008 Feb; 99(1-3):164-75. PubMed ID: 18053686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of alcohol dependence on social brain function.
    Gizewski ER; Müller BW; Scherbaum N; Lieb B; Forsting M; Wiltfang J; Leygraf N; Schiffer B
    Addict Biol; 2013 Jan; 18(1):109-20. PubMed ID: 22340281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Very poor outcome schizophrenia: clinical and neuroimaging aspects.
    Mitelman SA; Buchsbaum MS
    Int Rev Psychiatry; 2007 Aug; 19(4):345-57. PubMed ID: 17671868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using brain imaging measures in studies of procognitive pharmacologic agents in schizophrenia: psychometric and quality assurance considerations.
    Barch DM; Mathalon DH
    Biol Psychiatry; 2011 Jul; 70(1):13-8. PubMed ID: 21334602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Social-Cognitive Deficits in Schizophrenia.
    Mier D; Kirsch P
    Curr Top Behav Neurosci; 2017; 30():397-409. PubMed ID: 26728167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adapting social neuroscience measures for schizophrenia clinical trials, Part 1: ferrying paradigms across perilous waters.
    Green MF; Lee J; Ochsner KN
    Schizophr Bull; 2013 Nov; 39(6):1192-200. PubMed ID: 24072811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. White matter abnormalities and neurocognitive deficits associated with the passivity phenomenon in schizophrenia: a diffusion tensor imaging study.
    Sim K; Yang GL; Loh D; Poon LY; Sitoh YY; Verma S; Keefe R; Collinson S; Chong SA; Heckers S; Nowinski W; Pantelis C
    Psychiatry Res; 2009 May; 172(2):121-7. PubMed ID: 19297135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the efficacy of transcranial direct current stimulation in the treatment of cognitive symptomatology in the early stages of psychosis: study protocol for a double-blind randomized controlled trial.
    Rabanea-Souza T; Cirigola SMC; Noto C; Gomes JS; Azevedo CC; Gadelha A; Cordeiro Q; Dias ÁM; Lacerda ALT
    Trials; 2019 Apr; 20(1):199. PubMed ID: 30953544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.